Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Dec 11.
Published in final edited form as: Immunohorizons. 2019 Jun 11;3(6):203–207. doi: 10.4049/immunohorizons.1900035

Deficiency of mucosal associated invariant T cells in TCRJα18 germline knockout mice

Jinhai Xie a,b, Yun Pan b, Huishan Tao a, Peng Wang a, Yongping Chen c, Jimin Gao b, Xiao-Ping Zhong a,d,e
PMCID: PMC6829908  NIHMSID: NIHMS1055852  PMID: 31356166

Abstract

Mucosal associated invariant T (MAIT) cells and invariant natural killer T (iNKT) cells account for the major lymphocyte populations that express invariant TCRα chains. MAIT cells mostly express the TCRVα19-Jα33 TCR in mice and the TCRVα7.2-Jα33 TCR in humans, while iNKT cells express the TCRVα14-Jα18 TCR in mice and the TCRVα24-Jα18 TCR in humans. Both MAIT and iNKT cells have the capacity to quickly produce a variety of cytokines in response to agonist stimuli and to regulate both innate and adaptive immunity. The germline TCRJα18 knockout (Traj18−/−) mice have been used extensively for studying iNKT cells. While it has been reported that the TCRα repertoire was narrowed and the level of Trav19-ja33 transcript was decreased in this strain of mice, direct assessment of MAIT cells in these mice has not been reported. We demonstrate here that this strain of mice is also defective of MAIT T cells, cautioning data interpretation when using this strain of mice.

Keywords: mucosal associated invariant T cells, MAIT cells, invariant Natural killer T cells, iNKT cells

Introduction

MAIT and iNKT cells account for the major lymphocyte populations that express invariant TCRα chains with a restricted TCR repertoire. MAIT cells mostly express the TCRVα19-Jα33 TCR in mice and the TCRVα7.2-Jα33 TCR in humans, while iNKT cells express the TCRVα14-Jα18 TCR in mice and the TCRVα24-Jα18 TCR in humans (15). Different from conventional TCRαβ+ T cells, iNKT and MAIT cells do not respond to peptides presented by classic MHC molecules, but instead recognize glycolipids and microbe-derived riboflavin (vitamin B2) metabolites presented by the MHC-I-related molecules CD1d and MR1, respectively (6, 7). Both iNKT and MAIT cells mature and differentiate into effector lineages in the thymus and are able to rapidly produce both proinflammatory and regulatory cytokines and exert other effector function (811). These cells play important roles in both innate and adaptive immunity against microbial infection and tumor but may also contribute to pathogenesis of diseases such as allergy, asthma, and autoimmune diseases (2, 1215). Many studies on iNKT cell pathophysiological functions have been performed using the Trja18−/− (TCRJα18−/−) mice that lack iNKT cells due to an essential role of the signal from the TCRVα14-Jα18 TCR for iNKT cell development (16). In TCRJα18−/− mice, the Traj18 segment is replaced with a neomycin resistance gene. While narrowed TCRα repertoire and decreased Trav19-ja33 transcript have been reported in TCRJα18−/− mice (17, 18), direct assessment of MAIT cells in this strain of mice has not been reported. We report here that TCRJα18−/− mice are virtually absent of MAIT cells in both thymus and peripheral organs, cautioning data interpretation when using this strain of mice.

Methods

Mice

TCRJα18−/− mice in C57BL6/J background were kindly provided by Drs. Kim Nichols, Luc Van Kaer, and Masaru Taniguchi. Some of these mice were crossed with Th1.1+CD45.1+ C57BL6/J mice. All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of Duke University. Single cell suspensions of the thymus, spleen, LNs, and liver MNCs were prepared as previous described (19). Single cell suspensions of the lung were made after collagenase digestion as reported previously (20). Cells were resuspended in Iscove’s Modified Dulbecco’s Medium containing 10% FBS (IMDM-10).

Antibodies and tetramers

Fluorochrome-conjugated anti-CD45.2 (clone 104), CD45.1 (A20), TCRγδ (clone GL3), TCRβ (clone H57–597), Gr1 (clone RB6-8C5), CD11b (clone M170), CD11c (clone N418), F4/80 (clone BM8), B220 (clone RA3-6B2), and 9/Erythroid Cells (clone TER-119) were purchased from Biolegend. PE- or APC-conjugated 5-OP-RU loaded MR-1 tetramer (MR1Tet) (8, 21) was kindly provided by the NIH tetramer facility. Dead cells were excluded using the Live/Dead Fixable Violet Dead Cell Stain (Invitrogen) or 7-AAD.

Enrichment of MAIT cells

MAIT cell enrichment was performed according to a published protocol (22) with modifications. Total thymocytes from individual mice in 200 μl IMDM-10 were stained on ice with APC- or PE-MR1tet at 1:200 dilution for 30 min with brief shaking of the cells every 10 minutes. After having been washed twice with IMDM with 1% FBS, cells were resuspended in 200 μl IMDM-10 with 10 μl microbeads conjugated with an anti-APC antibody (Miltenyl Biotec). After incubation on ice for another 30 min with gentle shaking every 10 min, the cells were mixed with 5 ml MACS buffer (PBS with 2mM EDTA and 0.5% BSA), pelleted by centrifugation, resuspended in 500 μl MACS buffer, and loaded on MACS LS columns (MACS #130-042-401) for positive selection following the manufacturer’s protocol. For MAIT cell analysis, single cell suspensions with or without MR1Tet enrichment were stained with anti-TCRβ, CD24, CD44, and other antibodies, and for unenriched cells, PE- or APC-conjugated 5-OP-RU loaded MR1-Tet at room temperature for 30 minutes. Lineage markers, including TCRγδ, CD11b, CD11c, F4/80, B220, Gr1, and Ter119, were included to exclude other cell lineages. MAIT cells were gated on live Lin TCRβ+MR1-Tet+ cells.

Generation of chimeric mice

For data in Figure 2A, CD45.2+ C57BL/6 mice were irradiated with a single dose of 800 rad X-Ray and intravenously injected with 10–15 million of a mixture of BM cells from CD45.1+CD45.2+ WT mice and CD45.1+ TCRJα18−/− mice at 1:1 ratio. For data in Figure 2B, CD45.1+ TCRJα18−/− mice were irradiated with a single dose of 600 rad X-Ray and intravenously injected with 15 million BM cells form WT CD45.2+ C57BL/6 mice. Recipient mice were euthanized and analyzed 8 weeks later.

Figure 2. Assessment of MAIT cell development in irradiation chimeric mice.

Figure 2.

A. MAIT cells, CD4+CD8+ DP, and TCRβ+ cells in the thymus of CD45.2+ recipient mice after irradiation and reconstitution with CD45.1+CD45.2+ WT and CD45.1+ TCRJα18−/− BM cells at a 1:1 ratio. B. Scatter plot shows percentages of indicated thymocyte populations from chimeric mice. C. MAIT cells in sublethally irradiated CD45.1+ Traj18−/− mice 8 weeks after reconstituted with CD45.2+ WT BM cells. Data shown are representative of or pooled from three experiments.

Statistical analysis

The scarcity of MAIT cells causes variations between experiments. To overcome this issue, we performed individual experiment examining a pair of age- and sex-matched test and control mice housed in the same cage. Each pair of mice in individual experiments was marked by a connecting line between test and control mice. Scatter plots were pooled multiple experiments and the numbers of pairs showed in the plots reflect the numbers of experiments performed. Comparisons were made by two-tailed Student t-test using the Prism 5/GraphPad software. P-values less than 0.05 were considered significant.

Results

Absence of MAIT cells in the thymus of TCRJα18−/− thymus

Using 5-OP-RU loaded MR1-tetramers (MR1Tet) to detect MAIT cells(21), it has been reported that MAIT cells are expanded in Cd1d−/− mice(22). We examined if MAIT cells would similarly expanded in TCRJα18−/− mice. In contrast to Cd1d−/− mice, MR1Tet+TCRβ+ MAIT cells were virtually absent in the thymus in TCRJα18−/− mice (Figure 1A1C). Because MAIT cells are very rare in the thymus, we further enriched MAIT cells from total thymocytes (Enrich. Thym) using APC- or PE-conjugated MR1Tet and anti-APC or -PE antibody-conjugated magnetic beads. We were able to greatly enrich MAIT cells from WT thymocytes and to confirm the absence of MAIT cells in the TCRJα18−/− thymus (Figure 1D1E).

Figure 1. Defective MAIT cell generation in TCRJα18−/− mice.

Figure 1.

A-C. Total thymocytes from WT and TCRJα18−/− mice were stained with TCRβ and MR1-Tetramer as well as lineage markers (CD11b, Gr1, F4/80, NK1.1, CD11c, Ter119, and B220) and LIVE/DEAD™ Viability/Cytotoxicity kit. A. Representative dot plots of live gated Lin thymocytes. B, C. MAIT cell percentages (B) and numbers (C). D-E. MAIT cells in thymocytes were enriched using PE- or APC-MR1Tet and MACS beads followed by staining and analysis similar to A-C. Dotted line connected samples represent sex-age matched WT and Tcrja18−/− mice examined in each experiment. Data shown are representative of or pooled from five experiments. *, p<0.05; **, p<0.01 determined by the pair-wised Student t-test.

Intrinsic defect of MAIT cell generation in TCRJα18−/− thymus

Because TCRJα18−/− mice are germline knockout and MAIT cells are positively selected by MR1 expressed on CD4+CD8+ double positive (DP) thymocytes, we generated irradiation chimeric mice (CD45.2+) with a mixture of bone marrow (BM) cells from CD45.1+CD45.2+ WT and CD45.1+ TCRJα18−/− mice at a 1:1 ratio to determine if cell intrinsic mechanisms caused MAIT cell deficiency in TCRJα18−/− mice. Eight weeks after reconstitution, MAIT cells were solely derived from WT donor but not TCRJα18−/− donor. In contrast, CD4+CD8+ DP thymocytes were equally generated from both origins, indicating equal reconstitution of hematopoietic stem cells (HSCs) from both origins (Figure 2A). Additionally, in sublethally irradiated CD45.1+ TCRJα18−/− mice reconstituted with CD45.2+ WT BM cells, MAIT cells were generated only from donor WT BM HSCs but TCRβ+ conventional T cells were generated from both donor and recipient HSCs (Figure 2B), suggesting that there was no gross abnormality of thymic environment in TCRJα18−/− mice for MAIT cell development. Together, these data indicate that intrinsic mechanisms cause MAIT cell deficiency in TCRJα18−/− mice.

Virtual absence of MAIT cells in peripheral organs in TCRJα18−/− mice

MAIT cells are localized in both mucosal tissues and peripheral lymphoid and non-lymphoid organs. We further examined MAIT cells in the spleen, lymph nodes (LNs), liver, and lung in TCRJα18−/− and WT control mice (Figure 3). MAIT cells were virtually undetectable in these organs in TCRJα18−/− mice, with total MAIT cell numbers decreased ranging from 96.3% to 99.4% in these organs. Thus, defective in MAIT cell generation caused virtual absence of these cells in the peripheral organs.

Figure 3. Deficiency of MAIT cells in the peripheral organs in TCRJA18−/− mice.

Figure 3.

A. Representative dot plots showing TCRβ and MR1-Tetramer staining in live gated Lin cells from the spleen and peripheral LNs and LinTCRβ+ cells from the lung and liver. B,C. MAIT cell percentages (B) and numbers (C) in these organs. Dotted line connected samples represent sex-age matched WT and Tcrja18−/− mice examined in each experiment. Data shown are representative of or pooled from five - six experiments. *, p<0.05; **, p<0.01; ***, p<0.001 determined by the pair-wised Student t-test.

Discussion

TCRJα18−/− mice have been widely used for studying iNKT cell functions due to their deficiency of iNKT cells. We have demonstrated here that this strain of TCRJα18−/− mice is also defective in MAIT cells. Virtually no MAIT cells are detected in both thymus and peripheral organs in these mice. Our data together with the observations of a narrowed T cell repertoire and a severe decrease TCRVα19-Jα33 transcript in TCRJα18−/− mice(17, 18) support the notion that the presence of the Neor cassette in the Traj18 region may reduce chromatin accessibility of Traj segments 5’ to the Neor distal to the Tra enhancer for Trav-j recombination or transcription. Given the extensive utilization of TCRJα18−/− mice for examining the pathophysiological functions of iNKT cells and important functions of MAIT cells, some of these data may need to be reexamined and reinterpreted. New strains of TCRJα18 deficient mice generated with either the Cre-LoxP technology (18, 23), or the transcription activator-like effector nuclease (TALEN) technology (24) should provide needed replacement of the TCRJα18−/− for interrogating iNKT cells. These two strains of TCRJα18 deficient mice created by Cre-Loxp technology, the B6(Cg)-Traj18tm1.1Kro/J mice (23), available in the Jackson Laboratory, and the other Traj18 deficient mice (18) display normal Traj33 usage or Trav1-ja33 expression within T cells, indicating that MAIT cell generation in these mice is not impaired. The deficiency of both iNKT and MAIT cells in TCRJα18−/− mice and the potential competition of MAIT cells and iNKT cells for the same niche indicated by marked increases of MAIT cells in CD1d−/− mice (22) suggest a possible utility of the TCRJα18−/− mice for investigating MAIT cell function via reconstitution.

Acknowledgement

We thank Drs. Masaru Taniguchi, Kim Nichols, and Luc Van Kaerfor providing the TCRJα18−/− mice, the NIH tetramer facility for providing CD1d tetramer and MR1 tetramer, and the flow cytometry core facility of Duke Cancer Institute for providing services.

The research is supported by funding from the National Institute of Allergy and Infectious Diseases (R01AI079088 and R01AI101206 for XPZ).

Footnotes

Conflict of interest

The authors declare no conflict of interest.

References

  • 1.Chandra S, and Kronenberg M. 2015. Activation and Function of iNKT and MAIT Cells. Adv Immunol 127: 145–201. [DOI] [PubMed] [Google Scholar]
  • 2.Bendelac A, Savage PB, and Teyton L. 2007. The biology of NKT cells. Annu Rev Immunol 25: 297–336. [DOI] [PubMed] [Google Scholar]
  • 3.Yang W, Gorentla B, Zhong XP, and Shin J. 2015. mTOR and its tight regulation for iNKT cell development and effector function. Mol Immunol 68: 536–545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, and Lantz O. 2011. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32: 212–218. [DOI] [PubMed] [Google Scholar]
  • 5.Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, and Moody DB. 2015. The burgeoning family of unconventional T cells. Nat Immunol 16: 1114–1123. [DOI] [PubMed] [Google Scholar]
  • 6.Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, Williamson NA, Purcell AW, Dudek NL, McConville MJ, O’Hair RA, Khairallah GN, Godfrey DI, Fairlie DP, Rossjohn J, and McCluskey J. 2012. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717–723. [DOI] [PubMed] [Google Scholar]
  • 7.Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, Affaticati P, Gilfillan S, and Lantz O. 2003. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422: 164–169. [DOI] [PubMed] [Google Scholar]
  • 8.Rahimpour A, Koay HF, Enders A, Clanchy R, Eckle SB, Meehan B, Chen Z, Whittle B, Liu L, Fairlie DP, Goodnow CC, McCluskey J, Rossjohn J, Uldrich AP, Pellicci DG, and Godfrey DI. 2015. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med 212: 1095–1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kawachi I, Maldonado J, Strader C, and Gilfillan S. 2006. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol 176: 1618–1627. [DOI] [PubMed] [Google Scholar]
  • 10.Napier RJ, Adams EJ, Gold MC, and Lewinsohn DM. 2015. The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Frontiers in immunology 6: 344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Franciszkiewicz K, Salou M, Legoux F, Zhou Q, Cui Y, Bessoles S, and Lantz O. 2016. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells. Immunol Rev 272: 120–138. [DOI] [PubMed] [Google Scholar]
  • 12.Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N, Piedavent M, and Friese MA. 2014. CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol 44: 3119–3128. [DOI] [PubMed] [Google Scholar]
  • 13.Leeansyah E, Ganesh A, Quigley MF, Sonnerborg A, Andersson J, Hunt PW, Somsouk M, Deeks SG, Martin JN, Moll M, Shacklett BL, and Sandberg JK. 2013. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121: 1124–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cho YN, Kee SJ, Kim TJ, Jin HM, Kim MJ, Jung HJ, Park KJ, Lee SJ, Lee SS, Kwon YS, Kee HJ, Kim N, and Park YW. 2014. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol 193: 3891–3901. [DOI] [PubMed] [Google Scholar]
  • 15.Santodomingo-Garzon T, and Swain MG. 2011. Role of NKT cells in autoimmune liver disease. Autoimmun Rev 10: 793–800. [DOI] [PubMed] [Google Scholar]
  • 16.Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, and Taniguchi M. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623–1626. [DOI] [PubMed] [Google Scholar]
  • 17.Bedel R, Matsuda JL, Brigl M, White J, Kappler J, Marrack P, and Gapin L. 2012. Lower TCR repertoire diversity in Traj18-deficient mice. Nat Immunol 13: 705–706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Dashtsoodol N, Shigeura T, Ozawa R, Harada M, Kojo S, Watanabe T, Koseki H, Nakayama M, Ohara O, and Taniguchi M. 2016. Generation of Novel Traj18-Deficient Mice Lacking Valpha14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire. PLoS One 11: e0153347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shen S, Chen Y, Gorentla BK, Lu J, Stone JC, and Zhong XP. 2011. Critical roles of RasGRP1 for invariant NKT cell development. J Immunol 187: 4467–4473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Deng W, Yang J, Lin X, Shin J, Gao J, and Zhong XP. 2017. Essential Role of mTORC1 in Self-Renewal of Murine Alveolar Macrophages. J Immunol 198: 492–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z, Eckle SB, Uldrich AP, Birkinshaw RW, Patel O, Kostenko L, Meehan B, Kedzierska K, Liu L, Fairlie DP, Hansen TH, Godfrey DI, Rossjohn J, McCluskey J, and Kjer-Nielsen L. 2013. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 210: 2305–2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Koay HF, Gherardin NA, Enders A, Loh L, Mackay LK, Almeida CF, Russ BE, Nold-Petry CA, Nold MF, Bedoui S, Chen Z, Corbett AJ, Eckle SB, Meehan B, d’Udekem Y, Konstantinov IE, Lappas M, Liu L, Goodnow CC, Fairlie DP, Rossjohn J, Chong MM, Kedzierska K, Berzins SP, Belz GT, McCluskey J, Uldrich AP, Godfrey DI, and Pellicci DG. 2016. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol 17: 1300–1311. [DOI] [PubMed] [Google Scholar]
  • 23.Chandra S, Zhao M, Budelsky A, de Mingo Pulido A, Day J, Fu Z, Siegel L, Smith D, and Kronenberg M. 2015. A new mouse strain for the analysis of invariant NKT cell function. Nat Immunol 16: 799–800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Zhang J, Bedel R, Krovi SH, Tuttle KD, Zhang B, Gross J, Gapin L, and Matsuda JL. 2016. Mutation of the Traj18 gene segment using TALENs to generate Natural Killer T cell deficient mice. Scient Rep 6: 27375. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES